Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Total Funding: $280M
Total Funding: $100M
Total Funding: $9.5M
Total Funding: $34M
Total Funding: $170M
Total Funding: $54M
Total Funding: $330M
Total Funding: $550M
Total Funding: $140M
Total Funding: $45M
Total Funding: $15M
Total Funding: $1.2B
Total Funding: $97M
2015
2022
● Investing in data-driven deep tech to improve human lives and planetary resiliency ● Focus areas include biotech, digital health, AI, robotics, agriculture, and more ● Notable investments: - Guardant Health (NASDAQ: GH) - Oscar Health (NYSE: OSCR) - Oxford Nanopore (LSE: ONT.L) - Metagenomi (NASDAQ: MGX) - GRAIL (acquired) - Atomwise - Color - Culture Biosciences - Karius - Locus Biosciences
2016 - 2022
2015 - 2016
2023
2018
2018
Investments include: Arpeggio Biosciences, Helium Health, Locus Biosciences, and more
2017 - 2020
2017 - 2020
2018 - 2020
2018 - 2020
2011 - 2015
2011 - 2015
● Built and directed a joint professional Master's program between UC Berkeley and UCSF ● Managed curriculum, projects, finances, recruiting, admissions, and more ● Grew program to ~30 students at steady state with a self-sustaining budget
2008 - 2011
2008 - 2011
● Led R&D of Class II medical devices for soft-tissue regeneration including peripheral nerves ● Expanded company's IP portfolio with multiple patent filings ● Helped secure early-stage financing including investments and grants
2007 - 2010
2007 - 2010
Co-author of a humorous science fiction guide book: Kyle Kurpinski and Terry D. Johnson. How to Defeat Your Own Clone: And Other Tips for Surviving the Biotech Revolution. New York: Bantam Dell, 2010.
2003 - 2008
2003 - 2008
● Conducted research spanning stem cells, tissue engineering, micro-/nano-fabrication, and more ● Published articles in PNAS, Nano Letters, Biomaterials, and more
2002 - 2002
2002 - 2002
● Discovered mutation site of sex-linked genetic disease without samples from affected patients ● Published findings in the American Journal of Medical Genetics